The combination of a strong earnings beat and a 10% owner's open-market purchases at current levels creates a favorable risk/reward setup. Monitor for any guidance updates or additional insider activity in the coming weeks, as the historical pattern on BDSX shows strong positive drift following similar signals.
Price Chart
Executive Summary
Biodesix 10% owner Jack Schuler made two open-market purchases totaling $666K at ~$24/share, following the company's Q2 2026 earnings beat (revenue $26.9M, +34% YoY, EPS -$0.71 vs consensus -$0.90). This insider buying represents ~0.26% of market cap, a modest but notable signal that aligns with strong operational momentum in diagnostic testing volumes (+38%) and expanding gross margins (82%).
Key Financial Metrics
Key Facts
- 10% owner Jack Schuler bought 27,600 shares total for $666K on 2026-08-10 and 2026-08-11
- Purchases at ~$24.01-$24.25 per share, representing ~0.26% of BDSX's $256M market cap
- Q2 2026 revenue $26.9M (+34% YoY) beat consensus; EPS -$0.71 beat -$0.90 estimate by 21.4%
- Diagnostic Testing revenue grew 42% YoY to $25.4M on 38% volume growth; gross margins 82%
- FY 2026 revenue guidance maintained at $108-114M; company remains unprofitable with $7.3M net loss
Financial Impact
Insider purchase of $666K (0.26% of market cap) following strong Q2 beat with 34% revenue growth
Risk Factors
- Company remains unprofitable with $7.3M net loss in Q2
- Insider buying at 0.26% of market cap is modest in absolute terms
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0000905148-26-003599 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | Press Release | $23.87 | awaiting T+20 | — | $21.26 (−10.93%) |
Oct 19, 2026 7d ago | Press Release | $23.40 | awaiting T+20 | — | $21.26 (−9.15%) |
Aug 15, 2026 10w ago | Institutional Cluster | $23.25 $27.70 | ▲ +19.14% | ▲ +21.12% | $21.26 (−8.56%) |
Aug 13, 2026 10w ago | Insider Buy | $24.00 $27.40 | ▲ +14.17% | ▲ +16.16% | $21.26 (−11.42%) |
Aug 12, 2026 10w ago | Insider Buy | $23.79 $26.97 | ▲ +13.35% | ▲ +15.09% | $21.26 (−10.63%) |
Aug 5, 2026 11w ago | 8-K | $22.10 $26.48 | ▲ +19.80% | ▲ +19.20% | $21.26 (−3.80%) |
Jun 1, 2026 21w ago | EFFECT | $15.27 $22.55 | ▲ +47.68% | ▲ +48.97% | $21.26 (+39.23%) |
May 4, 2026 24w ago | Press Release | $14.94 $15.44 | ▲ +3.35% | ▼ −1.61% | $21.26 (+42.30%) |
Apr 20, 2026 27w ago | Press Release | $13.17 $14.25 | ▲ +8.20% | ▲ +4.00% | $21.26 (+61.43%) |
Mar 20, 2026 31w ago | Press Release | $14.88 $13.17 | ▼ −11.46% | ▼ −20.78% | $21.26 (+42.92%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers